APA (7th ed.) Citation

Péron, J., Lambert, A., Munier, S., Ozenne, B., Giai, J., Roy, P., . . . Buyse, M. (2019). Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit. JNCI : Journal of the National Cancer Institute, 111(11), 1186. https://doi.org/10.1093/jnci/djz030

Chicago Style (17th ed.) Citation

Péron, Julien, et al. "Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit." JNCI : Journal of the National Cancer Institute 111, no. 11 (2019): 1186. https://doi.org/10.1093/jnci/djz030.

MLA (9th ed.) Citation

Péron, Julien, et al. "Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit." JNCI : Journal of the National Cancer Institute, vol. 111, no. 11, 2019, p. 1186, https://doi.org/10.1093/jnci/djz030.